Pakistan aims to restart Islamabad MoU implementation
The American pharmaceutical company Pfizer has obtained approval from U.S. and Japanese authorities to produce the first vaccine against IAVE (Insect-borne Acute Viral Encephalitis), a rare disease caused by a virus transmitted through insects, leading to brain inflammation. Pfizer will begin manufacturing the vaccine at a rate of one million doses annually, with availability expected within the next two years. The vaccine will be used to protect against the disease, which is considered a rare infectious disease that can cause serious health complications.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)